The contraceptives market in Spain, based on hormones or spermicides, witnessed a significant decline from 2013 to 2023, with the market value decreasing to $214.09 million USD by 2023. A year-on-year decline was particularly notable over the last two years, with decreases of 10.57% in 2022 and 11.7% in 2023. Over a five-year period, the compound annual growth rate (CAGR) showed an average decrease of 7.16% per annum. This declining trend suggests a shrinking market, prompting the need for strategic adjustments.
Future trends to watch for:
- Increased adoption of non-hormonal or alternative contraceptive methods may influence market size.
- Awareness campaigns and changing demographics could potentially revive demand.
- Technological innovations and improvements in accessibility may offer new growth opportunities.
How does Spain rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 6 | 6 Thailand | 74,049,000 | 2023 | -0.41% | +0.22% | View data |
